PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Addressing a Yellow Fever Vaccine Shortage - United States, 2016-2017.

Abstract Recent manufacturing problems resulted in a shortage of the only U.S.-licensed yellow fever vaccine. This shortage is expected to lead to a complete depletion of yellow fever vaccine available for the immunization of U.S. travelers by mid-2017. CDC, the Food and Drug Administration (FDA), and Sanofi Pasteur are collaborating to ensure a continuous yellow fever vaccine supply in the United States. As part of this collaboration, Sanofi Pasteur submitted an expanded access investigational new drug (eIND) application to FDA in September 2016 to allow for the importation and use of an alternative yellow fever vaccine manufactured by Sanofi Pasteur France, with safety and efficacy comparable to the U.S.-licensed vaccine; the eIND was accepted by FDA in October 2016. The implementation of this eIND protocol included developing a systematic process for selecting a limited number of clinic sites to provide the vaccine. CDC and Sanofi Pasteur will continue to communicate with the public and other stakeholders, and CDC will provide a list of locations that will be administering the replacement vaccine at a later date.
PMID
Related Publications

Evaluation of thermostable yellow fever vaccine from the Pasteur Institute on international travellers.

Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002.

Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015.

CDC Travelers’ Health Branch releases free, web-based training course Yellow Fever: Information for Health Care Professionals Advising Travelers.

Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors

Mayor MeshTerms

Public Health Administration

Keywords
Journal Title mmwr. morbidity and mortality weekly report
Publication Year Start




PMID- 28472025
OWN - NLM
STAT- MEDLINE
DA  - 20170504
DCOM- 20170516
LR  - 20170516
IS  - 1545-861X (Electronic)
IS  - 0149-2195 (Linking)
VI  - 66
IP  - 17
DP  - 2017 May 05
TI  - Addressing a Yellow Fever Vaccine Shortage - United States, 2016-2017.
PG  - 457-459
LID - 10.15585/mmwr.mm6617e2 [doi]
AB  - Recent manufacturing problems resulted in a shortage of the only U.S.-licensed
      yellow fever vaccine. This shortage is expected to lead to a complete depletion
      of yellow fever vaccine available for the immunization of U.S. travelers by
      mid-2017. CDC, the Food and Drug Administration (FDA), and Sanofi Pasteur are
      collaborating to ensure a continuous yellow fever vaccine supply in the United
      States. As part of this collaboration, Sanofi Pasteur submitted an expanded
      access investigational new drug (eIND) application to FDA in September 2016 to
      allow for the importation and use of an alternative yellow fever vaccine
      manufactured by Sanofi Pasteur France, with safety and efficacy comparable to the
      U.S.-licensed vaccine; the eIND was accepted by FDA in October 2016. The
      implementation of this eIND protocol included developing a systematic process for
      selecting a limited number of clinic sites to provide the vaccine. CDC and Sanofi
      Pasteur will continue to communicate with the public and other stakeholders, and 
      CDC will provide a list of locations that will be administering the replacement
      vaccine at a later date.
FAU - Gershman, Mark D
AU  - Gershman MD
FAU - Angelo, Kristina M
AU  - Angelo KM
FAU - Ritchey, Julian
AU  - Ritchey J
FAU - Greenberg, David P
AU  - Greenberg DP
FAU - Muhammad, Riyadh D
AU  - Muhammad RD
FAU - Brunette, Gary
AU  - Brunette G
FAU - Cetron, Martin S
AU  - Cetron MS
FAU - Sotir, Mark J
AU  - Sotir MJ
LA  - eng
PT  - Journal Article
DEP - 20170505
PL  - United States
TA  - MMWR Morb Mortal Wkly Rep
JT  - MMWR. Morbidity and mortality weekly report
JID - 7802429
RN  - 0 (Drugs, Investigational)
RN  - 0 (Yellow Fever Vaccine)
SB  - IM
MH  - Drug Approval
MH  - Drugs, Investigational
MH  - Humans
MH  - *Public Health Administration
MH  - Travel
MH  - United States
MH  - Yellow Fever/*prevention & control
MH  - Yellow Fever Vaccine/*supply & distribution
EDAT- 2017/05/05 06:00
MHDA- 2017/05/17 06:00
CRDT- 2017/05/05 06:00
AID - 10.15585/mmwr.mm6617e2 [doi]
PST - epublish
SO  - MMWR Morb Mortal Wkly Rep. 2017 May 5;66(17):457-459. doi:
      10.15585/mmwr.mm6617e2.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>